Skip to main content
. 2021 Jun 29;10:95. doi: 10.1186/s13756-021-00961-4

Table 3.

Recommendations to facilitate molecular test uptake

Concern raised during interview Recommendation
Unfamiliarity with molecular diagnostics Publicise the technology’s purpose and benefits, particularly its rapidity, accuracy, and ability to facilitate targeted antimicrobial therapy
Identify and address any misconceptions held by clinicians
Establish a trial period for clinician first-hand familiarisation
Withholding antibiotics until receiving molecular diagnostic results Emphasise that empiric antibiotics can be started and refined after molecular diagnostic results become available